Brooklyn ImmunoTherapeutics Revenue and Competitors

Location

N/A

Total Funding

Industry

Estimated Revenue & Valuation

  • Brooklyn ImmunoTherapeutics's estimated annual revenue is currently $1.7M per year.(i)
  • Brooklyn ImmunoTherapeutics's estimated revenue per employee is $130,769

Employee Data

  • Brooklyn ImmunoTherapeutics has 13 Employees.(i)
  • Brooklyn ImmunoTherapeutics grew their employee count by -13% last year.

Brooklyn ImmunoTherapeutics's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
EVP Clinical OperationsReveal Email/Phone
3
Chief Development OfficerReveal Email/Phone

What Is Brooklyn ImmunoTherapeutics?

keywords:N/A

N/A

Total Funding

13

Number of Employees

$1.7M

Revenue (est)

-13%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Brooklyn ImmunoTherapeutics News

2022-04-17 - Brooklyn ImmunoTherapeutics stock rises ~7% on setting up of new R&D facility

Brooklyn ImmunoTherapeutics (NASDAQ:BTX) said it has set up a new corporate and research and development facility at The Boardwalk at...

2022-04-17 - Brooklyn ImmunoTherapeutics Announces Establishment of New ...

SAN DIEGO, April 21, 2022 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (Nasdaq:BTX) (“Brooklyn”), a biopharmaceutical company...

2022-04-13 - Brooklyn ImmunoTherapeutics Announces Fourth Quarter and Full ...

(Nasdaq:BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring the role that cytokine, gene editing, and cell therapy can have in...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.4M13-24%N/A
#2
$1.4M13N/AN/A
#3
$1.1M13N/AN/A
#4
$2.1M13N/AN/A
#5
$1.4M13N/AN/A